SEC Form 4 · accession 0001209191-15-079163
Armata Pharmaceuticals, Inc. · ARMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vijay B Samant
Director
Period of report
Nov 5, 2015
Accepted (ET)
Nov 9, 2015 · 5:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921114
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.65 | Nov 5, 2015 | A | 16,200 | A | — | Nov 4, 2025 | Common Stock | 16,200 | 16,200 | D |
Explanation of responses
- F125% of the shares subject to the Stock Option shall vest on November 5, 2016, and the remaining shares shall vest in 36 equal monthly installments thereafter.